Updating results

70 results for IBD Sort: Relevance | Date

Inflammatory bowel disease (QS81)

Evidence-based statements to deliver quality improvements in diagnosing and managing inflammatory bowel disease in adults, children and young people

Quality standard Published February 2015

MIB109: RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease

Advice on the use of RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (IBD) to aid local decision-making

Medtech innovation briefing Published June 2017

Leukapheresis for inflammatory bowel disease (IPG126)

Evidence-based recommendations on leukapheresis for inflammatory bowel disease (IBD) (ulcerative colitis and Crohn's disease)

Interventional procedures guidance Published June 2005

Inflammatory bowel disease

All NICE products on Inflammatory bowel disease. Includes any guidance, advice, NICE Pathways and quality standards.

MIB132: Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease

Advice on the use of point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease

Medtech innovation briefing Published December 2017

Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas (CG118)

Evidence-based recommendations on colonoscopic surveillance to prevent colorectal cancer in people with ulcerative colitis, Crohn’s disease or adenomas

Clinical guideline Published March 2011

Crohn's disease

Everything NICE has said on managing Crohn's disease in children, young people and adults in an interactive flowchart

NICE Pathway Published October 2012 Last updated January 2019

Ulcerative colitis

Everything NICE has said on managing ulcerative colitis in adults, children and young people in an interactive flowchart

NICE Pathway Published June 2013 Last updated November 2018

Irritable bowel syndrome in adults

Everything NICE has said on diagnosing and managing irritable bowel syndrome in adults in primary care in an interactive flowchart

NICE Pathway Published October 2012 Last updated October 2017

Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (DG11)

Evidence-based recommendations on faecal calprotectin diagnostic tests for inflammatory diseases of the bowel

Diagnostics guidance Published October 2013

Colonoscopic surveillance

Everything NICE has said on colonoscopic surveillance for people with inflammatory bowel disease or adenomas in an interactive flowchart.

NICE Pathway Published November 2011 Last updated November 2016

Natural history of progression to colorectal cancer in people at increased risk:- What is the natural history of progression to colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas?

history of progression to colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas? Any explanatory...

Research recommendation Published June 2015

Surveillance programmes for people at increased risk of colorectal cancer:- How effective are colonoscopic surveillance programmes in improving overall survival and cancer-related survival in people at increased risk of colorectal cancer?

Although there is some observational evidence in people with inflammatory bowel disease (IBD), there is no evidence in...

Research recommendation Published June 2015

Spondyloarthritis in over 16s: diagnosis and management (NG65)

Evidence-based recommendations on diagnosing and managing spondyloarthritis that is suspected or confirmed in over 16s

NICE guideline Published February 2017 Last updated June 2017

Effectiveness of biomarkers for determining level of risk of colorectal cancer:- Which biomarkers, including epigenic and genetic markers, are predictors of colorectal cancer? How should these be used to improve risk stratification?

and genetic markers, for colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas. Research should be...

Research recommendation Published June 2015

Patient experience in adult NHS services

Everything NICE has said on improving the experience of care for people using adult NHS services in an interactive flowchart

NICE Pathway Published March 2012 Last updated December 2017

MIB104: NaviCam for diagnosing gastrointestinal tract conditions

Advice on the use of NaviCam for diagnosing gastrointestinal (GI) tract and small bowel conditions to aid local decision-making

Medtech innovation briefing Published May 2017

Extracorporeal photopheresis for Crohn's disease (IPG288)

Evidence-based recommendations on extracorporeal photopheresis (treated white blood cells) for Crohn's disease

Interventional procedures guidance Published February 2009

Faecal incontinence in adults: management (CG49)

Evidence-based recommendations on the management of faecal incontinence in adults

Clinical guideline Published June 2007

KTT15: Biosimilar medicines

infliximab: a successful managed switch programme in people with inflammatory bowel disease discusses the outcomes of a managed...

Key therapeutic topic Published February 2016 Last updated February 2018

Osteoporosis: assessing the risk of fragility fracture (CG146)

Evidence-based recommendations on assessing the risk of osteoporosis-related fragility fractures in adults

Clinical guideline Published August 2012 Last updated February 2017

Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care (DG30)

Evidence-based recommendations on quantitative faecal immunochemical tests (OC Sensor, HM-JACKarc and FOB Gold) to guide GP referral for colorectal cancer

Diagnostics guidance Published July 2017

Shared learning award winners and finalists

A faecal calprotectin care pathway to support diagnosing inflammatory bowel diseases in primary care Yorkshire and Humber AHSN Download...

Published August 2018

Insertion of a collagen plug to close an abdominal wall enterocutaneous fistula (IPG507)

Evidence-based recommendations on inserting a collagen plug to close an abdominal wall enterocutaneous fistula

Interventional procedures guidance Published November 2014

ESNM1: Clostridium difficile infection: fidaxomicin

Summary of the evidence on fidaxomicin for treating Clostridium difficile (C. diff/C. difficile) infection to inform local NHS planning and decision-making

Evidence summary Published July 2012

Negative pressure wound therapy for the open abdomen (IPG467)

Evidence-based recommendations on negative pressure (vacuum therapy) wound therapy for the open (exposed) abdomen to aid healing

Interventional procedures guidance Published November 2013

Irritable bowel syndrome in adults: diagnosis and management (CG61)

Evidence-based recommendations on diagnosing and managing irritable bowel syndrome (IBS) in adults

Clinical guideline Published February 2008 Last updated April 2017

Crohn's disease: management (CG152)

Evidence-based recommendations on managing Crohn's disease in adults, young people and children

Clinical guideline Published October 2012 Last updated May 2016

Spondyloarthritis (QS170)

Evidence-based statements to deliver quality improvements in diagnosing and managing spondyloarthritis in adults aged 16 and over

Quality standard Published June 2018

Tofacitinib for moderately to severely active ulcerative colitis (TA547)

Evidence-based recommendations on tofacitinib (Xeljanz) for previously treated moderately to severely active ulcerative colitis in adults

Technology appraisal guidance Published November 2018

ESNM58: Ulcerative colitis: budesonide multimatrix (Cortiment)

Summary of the evidence on budesonide multimatrix (Cortiment) for treating ulcerative colitis (UC) to inform local NHS planning and decision-making

Evidence summary Published June 2015

Ustekinumab for moderately to severely active Crohn's disease after previous treatment (TA456)

Evidence-based recommendations on ustekinumab (Stelara) for previously treated moderately to severely active Crohn’s disease in adults

Technology appraisal guidance Published July 2017

Spondyloarthritis

Everything NICE has said on diagnosing and managing spondyloarthritis in people aged 16 and over in an interactive flowchart

NICE Pathway Published February 2017 Last updated October 2018

Osteoporosis

Everything NICE has said on assessing the risk of, preventing and treating osteoporotic fragility fractures in adults in an interactive flowchart

NICE Pathway Published August 2012 Last updated February 2018

Faecal incontinence

Everything NICE has said on managing faecal incontinence in adults in an interactive flowchart

NICE Pathway Published February 2013 Last updated January 2019

Eluxadoline for treating irritable bowel syndrome with diarrhoea (TA471)

Evidence-based recommendations on eluxadoline (Truberzi) for treating irritable bowel syndrome (IBS) with diarrhoea in adults

Technology appraisal guidance Published August 2017

Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy (TA352)

Evidence-based recommendations on vedolizumab (Entyvio) for moderately to severely active Crohn's disease if TNF-alpha therapy has not worked or...

Technology appraisal guidance Published August 2015

MIB126: Promonitor for monitoring response to biologics in rheumatoid arthritis

Advice on Promonitor to monitor response to biologics (etanercept, infliximab and its biosimilars, adalimumab, rituximab, golimumab) in rheumatoid arthritis to

Medtech innovation briefing Published October 2017

ESUOM30: Pouchitis: rifaximin

Summary of the evidence on rifaximin for treating pouchitis to inform local NHS planning and decision-making

Evidence summary Published March 2014